Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |